OKYO Pharma Ltd (LSE:OKYO) - Share price


Stock Report

OKYO Pharma Ltd OKYO

Last Price
GBX2.25

Day Change
0.00|0.00%

As of 17/07/2019
13:45:13 BST | GBX
Minimum 15 Minutes Delay.

Last Close2.25p
Day Range2.11 - 2.13
Mkt Cap12.61Mil
52-Wk Range1.00 - 8.00
Yield %-
ISINGG00BD3FV870
Volume94,210
P/E-7.45
P/S-
P/CF-0.09

Share Price

Total Returns 17/07/2019

 Chg (%)  
More ...
OKYO Pharma Ltd12.50 
FTSE 100 TR GBP2.56
 
Financials
201620172018
More ...
Income Statement
Turnover---
Operating Profit-0.76-0.29-0.84
Net Profit-0.70-0.19-53.15
Reported EPS-0.18-0.10-14.00
Balance Sheet
Current Assets3.7455.062.01
Non Current Assets18.660.000.00
Total Assets22.4055.062.01
Current Liabilities0.130.170.09
Total Liabilities---
Total Equity22.2754.891.92
Cash Flow
Operating Cash Flow-0.45-0.52-1.00
Net Change in Cash-0.68-0.52-1.00

Company Profile

OKYO Pharma Corp is engaged in the exploration and development of minerals mainly iron ore mining. The Company has an operation in Cameroon at the holding level.

Sector

Biotechnology

Index

Next Event 21/08/2019

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-43.69
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive DirectorMr. Willy Jules Simon
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.